A majority of pharmacies are committed to implementing an electronic prior authorization (ePA) solution that sends prior authorization requests electronically to the prescriber.
A majority (83%) of pharmacies have publicly announced that they are committed to implementing an electronic prior authorization (ePA) solution that sends prior authorization requests electronically to the prescriber (a 13% increase over Q1 2015), according to a new report summarizing the state of the ePA.
Overall, the report illustrates positive strides toward industry-wide adoption of ePA, according to healthcare technology company CoverMyMeds, which published the ePA National Adoption Scorecard report, which documents the increase in ePA availability in electronic health records (EHR) systems with payers and at pharmacies.
The October 2015 ePA National Adoption Scorecard found that 70% of EHR systems, representing the majority of market share, are committed to ePA (a 16% increase from Q1 2015). Eighty-seven percent of payers, representing the majority of market share, are committed to ePA (a 20% increase from Q1 2015).
In addition, 82% percent of pharmacies reported that the company and the ePA vendor have completed the integration work required for the ePA solution (a 15% increase over Q1 2015), and 72% reported the system was already operational (a 5% increase from Q1 2015).
CVS/pharmacy is the last major chain not yet committed to an ePA. The report notes that many independent pharmacies have access to ePA functionality through pharmacy systems, most of which have live, integrated ePA capabilities.
Prior authorization (PA) legislation has been considered, and in some states is in effect, since 2013 (see the state-by-state map). Currently, 23 states have passed legislation pertaining to PA, and 4 additional states have pending legislation. The legislation seeks to make the PA submission process faster and easier for providers to prevent the delay of patient treatment. However, there is no federal direction on PA, so each state is on its own with respect to creating and enacting PA legislation. The bills can simply update how paper forms are used, provide only an option for electronic submission, or mandate true ePA, according to CoverMyMeds.
CoverMyMeds recommends the swift and complete adoption of ePA by EHR vendors, payers, and pharmacies, leveraging functionality from ePA vendors to create the best PA process for the industry.
CoverMyMeds assists healthcare providers, and pharmacist complete ePA requests for any drug and all health insurance plans with technology that integrates with pharmacy systems, EHRs and pharmacy benefit managers to create an efficient ePA strategy.
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More
2 Commerce Drive
Cranbury, NJ 08512